CLINICAL TRIALS PROFILE FOR HYDRODIURIL
✉ Email this page to a colleague
All Clinical Trials for Hydrodiuril
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00797862 ↗ | Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension | Completed | Novartis | Phase 3 | 2008-11-01 | This study will compare the safety and efficacy of initial combination treatment with aliskiren + amlodipine to sequential add-on treatment strategies with aliskiren or amlodipine in patients with hypertension. |
NCT00896389 ↗ | Salt Loading and Thiazide Intervention Study | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 4 | 2009-10-01 | The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension. |
NCT00896389 ↗ | Salt Loading and Thiazide Intervention Study | Completed | University of Maryland | Phase 4 | 2009-10-01 | The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension. |
NCT00896389 ↗ | Salt Loading and Thiazide Intervention Study | Completed | University of Maryland, Baltimore | Phase 4 | 2009-10-01 | The investigators of this study propose to examine the relationships between STK39 (Serine Threonine Kinase 39) genotypes and responses to salt loading and to thiazide diuretics, hydrochlorothiazide. The investigators hypothesize that STK39 genotypes will be associated with the outcome of both interventions and can contribute to personalized care for hypertension. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Hydrodiuril
Condition Name
Clinical Trial Locations for Hydrodiuril
Trials by Country
Clinical Trial Progress for Hydrodiuril
Clinical Trial Phase
Clinical Trial Sponsors for Hydrodiuril
Sponsor Name
Sponsor Name for Hydrodiuril | |
Sponsor | Trials |
University of California, San Diego | 2 |
The First Affiliated Hospital of Anhui Medical University | 1 |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
[disabled in preview] | 1 |
This preview shows a limited data set Subscribe for full access, or try a Trial |